Understanding the Limitations of Haemoglobinopathy Testing Technologies
Learn about the strengths and limitations of the analytical technologies commonly used in haemoglobinopathy screening and diagnosis.
How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis
This webinar is presented in English.
Abstract
External Quality Assessment is an established component of quality assurance in laboratory medicine; however, a high-quality, educationally oriented EQA program offers the laboratory far more than the fulfilment of the requirements of ISO 15189 standards. Each exercise provides a learning opportunity and a chance to examine patterns of laboratory practices. This webinar will draw on EQA data and selected EQA case studies to illustrate the collective benefits of EQA in haemoglobinopathy testing, extending beyond the simple identification of laboratories which results that deviate from the consensus.
Attendance at this webinar will support the following learning outcomes:
- An understanding of the limitations of the technologies used for haemoglobinopathy testing.
- An understanding of how EQA can assist in the implementation of haemoglobinopathy screening guidelines.
- A demonstration of the educational opportunities inherent in EQA for haemoglobinopathies.
What will you learn?
Using EQA to Support Screening Best Practices
Discover how External Quality Assessment (EQA) programs help laboratories implement haemoglobinopathy screening guidelines and improve testing quality.
The Educational Value of EQA Case Studies
Explore real-world EQA data and case studies that highlight learning opportunities, promote consistency in laboratory practice, and enhance diagnostic performance.
Good EQA or proficiency testing is more than just an annual tick-box exercise, especially in a complex specialty such as hemoglobinopathies.
About Dr Barbara DE LA SALLE
Barbara DE LA SALLE is a Consultant Clinical Scientist and Director of the UK NEQAS External Quality Assessment scheme for Haematology. Before joining UK NEQAS in 2001, she worked for many years in clinical laboratories, initially in general haematology and later developing her long term career interest in the laboratory diagnosis of inherited red blood cell disorders at St Bartholomew’s and The Royal London Hospitals in Central London. She is President Elect of the UK NEQAS Charity and a Board Member of the International Society for Laboratory Haematology.
Test associated with this resource
Deepen your expertise with additional webinars
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country. Please contact your local Sebia representative. Information intended for healthcare professionals. Carefully read the instructions in the reagent package inserts and instrument manuals.